Julie Wilson

1.0k total citations
19 papers, 805 citations indexed

About

Julie Wilson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Julie Wilson has authored 19 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Julie Wilson's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Neonatal Respiratory Health Research (3 papers). Julie Wilson is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Neonatal Respiratory Health Research (3 papers). Julie Wilson collaborates with scholars based in United Kingdom, United States and Saudi Arabia. Julie Wilson's co-authors include John A. Steinkamp, George C. Saunders, Carleton C. Stewart, Donna Fitzsimons, Ana V. Perez-Castro, Michael R. Altherr, J.S. Elborn, J. MacMahon, Joshua L. Brown and Sara A. Rafferty and has published in prestigious journals such as Science, The Lancet and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Julie Wilson

19 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Wilson United Kingdom 11 208 165 147 106 101 19 805
Howard Hait United States 20 379 1.8× 135 0.8× 150 1.0× 107 1.0× 61 0.6× 27 1.3k
N. F. Coghill United Kingdom 23 85 0.4× 157 1.0× 94 0.6× 72 0.7× 84 0.8× 66 1.2k
Manuel Bayona United States 19 136 0.7× 48 0.3× 120 0.8× 115 1.1× 52 0.5× 45 960
R Rowe Canada 13 253 1.2× 155 0.9× 71 0.5× 23 0.2× 126 1.2× 23 1.1k
Krzysztof Czajkowski Poland 16 305 1.5× 80 0.5× 121 0.8× 70 0.7× 78 0.8× 138 1.1k
Donna L. Vredevoe United States 21 206 1.0× 95 0.6× 144 1.0× 414 3.9× 113 1.1× 60 1.4k
Mark Sullivan United Kingdom 18 183 0.9× 120 0.7× 150 1.0× 240 2.3× 38 0.4× 39 1.1k
Heather E. Bryant Canada 18 307 1.5× 116 0.7× 90 0.6× 31 0.3× 79 0.8× 41 1.1k
M. E. Grandolfo Italy 18 214 1.0× 53 0.3× 108 0.7× 35 0.3× 84 0.8× 55 853
Elizabeth Livingston United States 19 231 1.1× 95 0.6× 125 0.9× 35 0.3× 62 0.6× 48 1.2k

Countries citing papers authored by Julie Wilson

Since Specialization
Citations

This map shows the geographic impact of Julie Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Wilson more than expected).

Fields of papers citing papers by Julie Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Wilson. The network helps show where Julie Wilson may publish in the future.

Co-authorship network of co-authors of Julie Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Wilson. A scholar is included among the top collaborators of Julie Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Wilson. Julie Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wilson, Julie, et al.. (2020). Epidemiological Analysis of Antimicrobial Resistance in Staphylococcus epidermidis in Scotland, 2014–2018. Microbial Drug Resistance. 27(4). 485–491. 3 indexed citations
2.
Guy, Rebecca, Robin Howe, Berit Müller‐Pebody, et al.. (2016). Non-susceptibility ofEscherichia coli,Klebsiellaspp.,Pseudomonasspp.,Streptococcus pneumoniaeandStaphylococcus aureusin the UK: temporal trends in England, Northern Ireland, Scotland and Wales. Journal of Antimicrobial Chemotherapy. 71(6). 1564–1569. 10 indexed citations
3.
McConkey, Roy, et al.. (2013). Female gender doubles pre-hospital delay times for patients experiencing ST segment elevation myocardial infarction in Saudi Arabia. European Journal of Cardiovascular Nursing. 13(5). 399–407. 35 indexed citations
4.
Wilson, Julie & Kate Taylor. (2011). Clinical risk management in out-of-hours services. Nursing Management. 17(10). 26–30. 4 indexed citations
5.
Wilson, Julie, J.S. Elborn, Donna Fitzsimons, & Evie McCrum-Gardner. (2011). Do smokers with chronic obstructive pulmonary disease report their smoking status reliably? A comparison of self-report and bio-chemical validation. International Journal of Nursing Studies. 48(7). 856–862. 17 indexed citations
6.
Wilson, Julie, J.S. Elborn, & Donna Fitzsimons. (2010). ‘It’s not worth stopping now’: why do smokers with chronic obstructive pulmonary disease continue to smoke? A qualitative study. Journal of Clinical Nursing. 20(5-6). 819–827. 33 indexed citations
7.
Fitzsimons, Donna, Julie Wilson, Benjamin Corcoran, et al.. (2007). The challenge of patients' unmet palliative care needs in the final stages of chronic illness. Palliative Medicine. 21(4). 313–322. 212 indexed citations
8.
Wilson, Julie, et al.. (2007). Education in Pulmonary Rehabilitation: The Patient’s Perspective. Archives of Physical Medicine and Rehabilitation. 88(12). 1704–1709. 52 indexed citations
9.
Wilson, Julie, Donna Fitzsimons, Ian Bradbury, & J.S. Elborn. (2006). Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial. International Journal of Nursing Studies. 45(4). 508–517. 44 indexed citations
10.
Perez-Castro, Ana V., Julie Wilson, & Michael R. Altherr. (1997). Genomic Organization of the Human Fibroblast Growth Factor Receptor 3 (FGFR3) Gene and Comparative Sequence Analysis with the MouseFgfr3Gene. Genomics. 41(1). 10–16. 67 indexed citations
11.
Perez-Castro, Ana V., Julie Wilson, & Michael R. Altherr. (1995). Genomic Organization of the Mouse Fibroblast Growth Factor Receptor 3 (Fgfr3) Gene. Genomics. 30(2). 157–162. 24 indexed citations
12.
Johnson, Neil F., Julie Wilson, R C Habbersett, et al.. (1990). Separation and characterization of basal and secretory cells from the rat trachea by flow cytometry. Cytometry. 11(3). 395–405. 10 indexed citations
13.
Wilson, Julie, et al.. (1988). Periodic response difference in mouse epidermis chronically exposed to crude-oils or BaP: Males vs. females. Toxicology. 50(1). 83–94. 5 indexed citations
14.
Johnson, Neil F., et al.. (1987). Preparation of viable single cell suspensions of tracheal epithelial cells.. PubMed. 68(2). 157–65. 5 indexed citations
15.
Wilson, Julie, John A. Steinkamp, & Bruce E. Lehnert. (1986). Isolation of viable type II alveolar epithelial cells by flow cytometry. Cytometry. 7(2). 157–162. 15 indexed citations
16.
Steinkamp, John A., Julie Wilson, George C. Saunders, & Carleton C. Stewart. (1982). Phagocytosis: Flow Cytometric Quantitation with Fluorescent Microspheres. Science. 215(4528). 64–66. 240 indexed citations
17.
Wilson, Julie, et al.. (1982). The effect of application frequency on epidermal carcinogenesis assays. Toxicology. 24(1). 45–53. 10 indexed citations
18.
Thomas, R.G., et al.. (1980). Multispecies retention parameters for cadmium. Environmental Research. 23(1). 191–207. 10 indexed citations
19.
Porter, I. A. & Julie Wilson. (1963). STAPHYLOCOCCAL INFECTIONS TREATED WITH FUSIDIC ACID IN NURSES. The Lancet. 282(7309). 658–659. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard Hait Breakdown of academic impact, for papers by N. F. Coghill Breakdown of academic impact, for papers by Manuel Bayona Breakdown of academic impact, for papers by R Rowe Breakdown of academic impact, for papers by Krzysztof Czajkowski Breakdown of academic impact, for papers by Donna L. Vredevoe Breakdown of academic impact, for papers by Mark Sullivan Breakdown of academic impact, for papers by Heather E. Bryant Breakdown of academic impact, for papers by M. E. Grandolfo Breakdown of academic impact, for papers by Elizabeth Livingston
Rankless by CCL
2026